Guardian Pharmacy Services, Inc. (GRDN)

GRDN Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,171	1,046	908.91	792.07	735.96	698.29
Revenue Growth (YoY)	16.86%	15.10%	14.75%	7.62%	5.39%	16.31%
Cost of Revenue	939.06	837.88	723.04	630.81	588.96	554.83
Gross Profit	231.85	208.31	185.87	161.27	147	143.46
Selling, General & Admin	296	167.36	133.88	118.09	102.54	97.56
Operating Expenses	296	167.36	133.88	131.12	114.05	108.14
Operating Income	-64.15	40.95	51.99	30.15	32.95	35.32
Interest Expense	-3.6	-2.86	-1.93	-1.64	-2.16	-2.25
Other Non Operating Income (Expenses)	-0.39	-0.37	-0.4	-0.19	-0.25	-0.48
EBT Excluding Unusual Items	-68.14	37.72	49.66	28.33	30.54	32.6
Merger & Restructuring Charges	-	-	-	-	-0.25	-0.1
Other Unusual Items	-	-	-	-	-0.64	-1.12
Pretax Income	-68.14	37.72	49.66	28.33	29.66	31.37
Earnings From Continuing Operations	-68.32	37.72	49.66	28.33	29.66	31.37
Minority Interest in Earnings	-18.9	-13.82	-14.24	-12.01	-9.72	-9.63
Net Income	-87.21	23.9	35.42	16.31	19.94	21.75
Net Income to Common	-98.09	23.9	35.42	16.31	19.94	21.75
Net Income Growth	-	-32.52%	117.12%	-18.20%	-8.29%	48.15%
Free Cash Flow	35.55	56.26	31.75	49.22	44.27	41.62
Gross Margin	19.80%	19.91%	20.45%	20.36%	19.97%	20.54%
Operating Margin	-5.48%	3.91%	5.72%	3.81%	4.48%	5.06%
Profit Margin	-8.38%	2.28%	3.90%	2.06%	2.71%	3.11%
Free Cash Flow Margin	3.04%	5.38%	3.49%	6.21%	6.02%	5.96%
EBITDA	-44.82	59.18	68.55	46.68	50.2	51.17
EBITDA Margin	-3.83%	5.66%	7.54%	5.89%	6.82%	7.33%
D&A For EBITDA	19.33	18.23	16.56	16.53	17.26	15.85
EBIT	-64.15	40.95	51.99	30.15	32.95	35.32
EBIT Margin	-5.48%	3.91%	5.72%	3.81%	4.48%	5.06%

Source: S&P Capital IQ. Standard template. Financial Sources.